Long bone fracture healing: IGF-I concentrations and specific binding to erythrocytes

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 4, 1996, Pages 491-495

  Karachaliou, F H ^a   Stamogiannou, L ^a   Maravelias, K ^a   Bartsocas, C S ^a,b   Koutselinis, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Bone; Fracture healing; IGF I; IGF I binding

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FRACTURE HEALING; HUMAN; LONG BONE; MALE;

EID: 0029816367     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1996.9.4.491     Document Type: Article

References (31)

1. Koskinen EVS, Lindholm R, Nieminen RA, Puranen JP, Attila U. Human growth hormone in bone regeneration of non healing fractures. Calcif Tissue Res 1977; 22: 521-523.
2. Babayan R, Bethge R, von Fehrental R, Ten Hoff M. Test of biochemical effect in fracture healing in animal experiments. Med Welt 1979; 30: 1725-1732.
3. Zielkens KW, Senk G, Bubenzer J, Peters H. Tierexperimentelle Untersuchungen über den Einfluss von Wachstrumshormon auf die Frakturheilung Unfallheilkd 1980; 83: 446-449.
4. Bak B, Jorgensen PH, Andreassen TT. Dose response of growth hormone on fracture healing in the rat. Acta Orthop Scand 1990; 61: 54-57.
5. Bak B, Jorgensen PH, Andrassen TT. The stimulating effect of growth hormone on fracture healing is dependent on onset and duration of administration. Clin Orthop 1991; 264: 295-301.
6. Harris JM, Bean DA, Banks HH. Effect of phosphate supplementation, thyrocalcitonin and growth hormone on strength of fracture healing. Surg Forum 1975; 26: 519-521.
7. Northmore-Ball R, Wood MR, Meggit BF. A biochemical study on the effects of growth hormone in experimental fracture healing. J Bone Joint Surg (Br) 1982; 62: 391-392.
8. Lindholm RV, Koskinen EVS, Puranen J, Nieminen RA, Kairaluoma M, Attila V. Human growth hormone in the treatment of fresh fractures. Horm Metabol Res 1977; 9: 245-246.
9. Koskinen EVS, Lindholm RV, et al. Human growth hormone in delayed union and non-union of fractures. Int Orthop 1978; 1: 317-322.
10. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Invest 1968; 21 (Suppl 97): 77-89.
11. Scatchard G. The attractions of proteins for small molecules and ions. Ann NY Acad Sci 1949; 51: 600-605.
12. De Meyts P, Roth J. Cooperatively in ligand binding: a new graphic analysis. Biochem Biophys Res Comm 1975; 66: 1118-1126.
13. Isaksson OGP, Jansson JO, Cause IAM. Growth hormone stimulates longitudinal bone growth directly. Science 1982; 216: 1237-1239.
14. Schechter NL, Russell SM, Spencer EM, Nicoll CS. Evidence suggesting that the direct growth promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 1986; 83: 7932-7934.
15. Hsu JD, Robinson RA. Studies on the healing of long bone fractures in hereditary pituitary insufficient mice. J Surg Res 1969; 9: 535-536.
16. Misol S, Samaan N, Ponseti IV. Growth hormone in delayed fracture union Clin Orthop 1971; 74: 206-208.
17. Ashton IK, Deketl S. Fracture repair in the small dwarf mouse. Br J Exp Pathol 1983; 64: 479-486.
18. Clark RG, Carlsson LM, Robinson IC. Growth hormone secretory profiles in conscious female rat. J Endocrinol 1982; 114: 394-407.
19. Froesch ER, Schmid C, Schwander J, Zapf J. Actions of insulin-like growth factors. Ann Rev Physiol 1985; 47: 443-467.
20. Marcus R, Butterfield G, Holloway L, et al. Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990; 70: 519-527
21. Rudman D, Feller AG, Nagraf HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990; 323: 1-6.
22. Jennishe E, Skottner A, Hansson HA. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand 1987; 129: 9-15.
23. Hansson HA, Dahlin LB, Danielsen N, et al. Evidence indicating trophic importance of IGF-I in regenerating peripheral nerves. Acta Physiol Scand 1986; 126: 609-614.
24. Kikerby DJ, Ekeland A. No effect of systemic administration of somatomedin C on bone repair in rats. Acta Orthop Scand 1990; 61: 335-338.
25. Kikerby OJ, Ekeland A. No effects of local somatomedin C on bone repair. Acta Orthop Scand 1992; 63: 447-450.
26. Casser HR, Zilkens KW, Forst R, Burggemann A. Influence of bone and soft-tissue operations on serum concentrations of growth hormone, somatomedin C and alkaline phosphate. Arch Orthop Trauma Surg 1990; 109: 272-276.
27. Bak B, Addreassen TT. The effect of aging on fracture healing in the rat. Calcif Tissue Int 1989; 45: 292-297.
28. Rosenfeld RG, Dolla IA. Characterization of the somatomedin-C insulin-like growth factor (Sm-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by Sm-C/IGF-I and insulin. J Clin Endocrinol Metabol 1982; 55: 434-440.
29. Chernausek SD, Beach DC, Barach W, Sperlind MA. Characteristics of hepatic receptors for somatomedin-C/insulin like growth factor 1 and insulin in the developing human. J Clin Endocrinol Metab 1987; 64: 737-743
30. Marshall RN, Underwood LE, Voina SJ, Foushee DB, Van Wyk LL. Characterizations of the insulin and somatomedin-C receptors in human placental membranes. J Clin Endocrinol Metab 1974; 39: 283-292.
31. Orlowski CC, Chernausek SP. Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 1988; 122: 44-49.